17
May
The government on Monday said it identified 26 potential cases of bleeding and blood clotting in India due to the administration of the AstraZeneca vaccine in India.Serum Institute of India is producing Covishield vaccine in India in partnership with AstraZeneca. The Union Health Ministry said in a statement on Monday that over 23,000 adverse events have been reported since the vaccination drive involving Covishield and Covaxin vaccines started in the country and of these 700 cases were reported to be serious. The ministry is separately issuing advisories to healthcare workers and vaccine beneficiaries to encourage people to be aware of…
